Reporting withdrawals due to adverse events in single-attack acute migraine clinical trials

Cephalalgia. 2015 Apr;35(4):366-7. doi: 10.1177/0333102414540059. Epub 2014 Jul 14.

Authors

Peer Tfelt-Hansen¹, Julio Pascual²

Affiliations

¹ Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark ptha@regionh.dk.
² Neuroscience Area, Service of Neurology, University Hospital Central of Asturias and Ineuropa, Spain.

PMID: 25022695
DOI: 10.1177/0333102414540059

No abstract available

Publication types

Letter
Comment

MeSH terms

Calcitonin Gene-Related Peptide / physiology*
Calcitonin Gene-Related Peptide Receptor Antagonists*
Female
Humans
Male
Migraine Disorders / drug therapy*
Piperidines / administration & dosage*
Pyridines / administration & dosage*

Substances

Calcitonin Gene-Related Peptide Receptor Antagonists
Piperidines
Pyridines
Calcitonin Gene-Related Peptide